STRS Ohio’s Werewolf Therapeutics HOWL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-1,800
Closed -$7K 2148
2022
Q1
$7K Hold
1,800
﹤0.01% 2103
2021
Q4
$21K Hold
1,800
﹤0.01% 2109
2021
Q3
$30K Hold
1,800
﹤0.01% 2139
2021
Q2
$31K Buy
+1,800
New +$24.7K ﹤0.01% 2152

Other funds holding HOWL

STRS Ohio's HOWL Position: Q2 2022 in Review

STRS Ohio sold out of Werewolf Therapeutics (HOWL) in Q2 2022, closing a stake of 1,800 shares — an estimated $7K sold.

STRS Ohio first reported a position in HOWL in Q2 2021 and held it in 4 quarters. The position peaked at $31K in Q2 2021. 46 funds tracked by Wall St. Rank hold HOWL as of Q2 2022.

  • STRS Ohio reported no remaining Werewolf Therapeutics position as of Q2 2022 after selling out during the quarter.
  • STRS Ohio sold 1,800 Werewolf Therapeutics shares in Q2 2022, an estimated $7K.
  • STRS Ohio first reported a position in Werewolf Therapeutics in Q2 2021 and held it in 4 quarters.
  • STRS Ohio's Werewolf Therapeutics position peaked at $31K in Q2 2021.
  • 46 funds tracked by Wall St. Rank held Werewolf Therapeutics as of Q2 2022.

Based on STRS Ohio's 13F filing for Q2 2022, filed 25 Jul 2022.